Ayala Pharmaceuticals Inc (ADXS)

[Gantor50]

I also thought today's PPS action was quite weak considering the overall market. The only caveat I guess is that volume was light across the entire biotech sector, especially the small caps.

It's interesting that in a year where Big Pharma is flush with cash and chomping at the bit for M&A, that many small and mid cap Bios are still being shorted and suppressed and closer to yearly lows than yearly highs.